GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
GLOBUS MEDICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$75.65−1.06 (-1.38%)
Close on Oct 19, 2026
- Market cap
- $10.39B
- P/E (TTM)
- 19.3
- Dividend yield
- –
GLOBUS MEDICAL INC revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enabling Technologies [Member] | – | – | – | $132.34M | $142.60M | $144.22M | $154.00M | $139.76M | $129.12M | $127.10M | $120.22M | $117.00M | – | – |
| Musculoskeletal Solutions [Member] | – | – | – | $2.64B | $2.48B | $2.37B | $2.37B | $2.34B | $2.11B | $1.77B | $1.45B | $1.11B | – | – |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $2.51B | $2.49B | $2.37B | $2.22B | $2.10B | $2.00B | $2.00B | $1.97B | $1.78B | $1.53B | $1.28B | $1.02B | 79.7% | +19.2% |
| International | $637.99M | $612.04M | $571.34M | $545.64M | $524.14M | $509.81M | $519.29M | $509.58M | $453.99M | $369.88M | $288.71M | $204.28M | 20.3% | +21.7% |
From the segment and revenue-disaggregation notes of Globus Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.